The Use of Infliximab for Treatment of Hospitalized Patients with Acute Severe Ulcerative Colitis

Abstract

In this real-life experience of infliximab in patients with steroid-refractory severe UC, infliximab appears to be a viable rescue therapy. The majority of patients were discharged without surgery and 62% maintained response either as a bridge to azathioprine or maintenance infliximab.